Expression of p21 Protein Predicts Clinical Outcome in DLBCL Patients Over Age 60 Treated with R-CHOP but not CHOP: A prospective ECOG and SWOG correlative study of E4494

PURPOSE: To prospectively investigate the prognostic significance of p21 and p53 expression in diffuse large B cell lymphoma (DLBCL) in the context of the US Intergroup trial comparing conventional cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy to rituximab (R)-CHOP i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Winter, Jane N., Li, Shuli, Aurora, Vikas, Variakojis, Daina, Nelson, Beverly, Krajewska, Maryla, Zhang, Lijun, Habermann, Thomas M., Fisher, Richard I., Macon, William R., Chhanabhai, Mukesh, Felgar, Raymond E., Hsi, Eric D., Medeiros, L. Jeffrey, Weick, James K., Weller, Edie A., Melnick, Ari, Reed, John C., Horning, Sandra J., Gascoyne, Randy D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2865202/
https://ncbi.nlm.nih.gov/pubmed/20371683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-1219
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados